Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stop&Go: Intermittent vs Continuous Chemotherapy in HER2-negative Metastatic Breast Cancer
NCT01935492Phase 3Completed
- Sponsor
- Borstkanker Onderzoek Groep
- Start
- Nov 2010
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel in breast cancer, sponsored by Borstkanker Onderzoek Groep. Started Nov 2010; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01935492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935492.